help button home button Am J Pathol R & D Systems
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hinoi, T.
Right arrow Articles by Fearon, E. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hinoi, T.
Right arrow Articles by Fearon, E. R.
(American Journal of Pathology. 2001;159:2239-2248.)
© 2001 American Society for Investigative Pathology

Regular Article

Loss of CDX2 Expression and Microsatellite Instability Are Prominent Features of Large Cell Minimally Differentiated Carcinomas of the Colon

Takao Hinoi*, Masachika Tani*{dagger}, Peter C. Lucas{ddagger}, Karel Caca*, Rodney L. Dunn§, Ettore Macri&para, Massimo Loda&para, Henry D. Appelman{ddagger}, Kathleen R. Cho*{ddagger}§ and Eric R. Fearon*{ddagger}||§

From the Departments of Internal Medicine,*
Pathology,{ddagger}
and Human Genetics,||
and the Cancer Center,§
University of Michigan, Ann Arbor, Michigan; the Biology Division,{dagger}
National Cancer Center Research Institute, Chuo-ku, Tokyo, Japan; and the Department of Adult Oncology, Dana-Farber Cancer Institute, and the Department of Pathology,¶ Brigham & Women’s Hospital, Harvard Medical School, Boston, Massachusetts

Most large bowel cancers are moderately to well-differentiated adenocarcinomas comprised chiefly or entirely of glands lined by tall columnar cells. We have identified a subset of poorly differentiated colon carcinomas with a distinctive histopathological appearance that we term large cell minimally differentiated carcinomas (LCMDCs). These tumors likely include a group of poorly differentiated carcinomas previously described by others as medullary adenocarcinomas. To better understand the pathogenesis of these uncommon neoplasms, we compared molecular features of 15 LCMDCs to those present in 25 differentiated adenocarcinomas (DACs) of the colon. Tumors were examined for alterations commonly seen in typical colorectal carcinomas, including increased p53 and ß-catenin immunoreactivity, K-ras gene mutations, microsatellite instability, and loss of heterozygosity of markers on chromosomes 5q, 17p, and 18q. In addition, tumors were evaluated by immunohistochemistry for CDX2, a homeobox protein whose expression in normal adult tissues is restricted to intestinal and colonic epithelium. Markedly reduced or absent CDX2 expression was noted in 13 of 15 (87%) LCMDCs, whereas only 1 of the 25 (4%) DACs showed reduced CDX2 expression (P < 0.001). Nine of 15 (60%) LCMDCs had the high-frequency microsatellite instability phenotype, but only 2 of 25 (8%) DACs had the high-frequency microsatellite instability phenotype (P = 0.002). Our findings provide support for the hypothesis that the molecular pathogenesis of LCMDCs is distinct from that of most DACs. CDX2 alterations and DNA mismatch repair defects have particularly prominent roles in the development of LCMDCs.




This article has been cited by other articles:


Home page
 DevelopmentHome page
C. W. Maurer, M. Chiorazzi, and S. Shaham
Timing of the onset of a developmental cell death is controlled by transcriptional induction of the C. elegans ced-3 caspase-encoding gene
Development, April 1, 2007; 134(7): 1357 - 1368.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
F. Benahmed, I. Gross, D. Guenot, F. Jehan, E. Martin, C. Domon-Dell, T. Brabletz, M. Kedinger, J.-N. Freund, and I. Duluc
The Microenvironment Controls CDX2 Homeobox Gene Expression in Colorectal Cancer Cells
Am. J. Pathol., February 1, 2007; 170(2): 733 - 744.
[Abstract] [Full Text] [PDF]

Home page
 Nucleic Acids ResHome page
E. C. Chao and S. M. Lipkin
Molecular models for the tissue specificity of DNA mismatch repair-deficient carcinogenesis
Nucleic Acids Res., February 6, 2006; 34(3): 840 - 852.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
M. E. Witek, K. Nielsen, R. Walters, T. Hyslop, J. Palazzo, S. Schulz, and S. A. Waldman
The Putative Tumor Suppressor Cdx2 Is Overexpressed by Human Colorectal Adenocarcinomas
Clin. Cancer Res., December 15, 2005; 11(24): 8549 - 8556.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
L. S. Rozek, S. M. Lipkin, E. R. Fearon, S. Hanash, T. J. Giordano, J. K. Greenson, R. Kuick, D. E. Misek, J. M.G. Taylor, J. A. Douglas, et al.
CDX2 Polymorphisms, RNA Expression, and Risk of Colorectal Cancer
Cancer Res., July 1, 2005; 65(13): 5488 - 5492.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Gastrointest. Liver Physiol.Home page
M.-L. Wang, M. E. Shin, P. A. Knight, D. Artis, D. G. Silberg, E. Suh, and G. D. Wu
Regulation of RELM/FIZZ isoform expression by Cdx2 in response to innate and adaptive immune stimulation in the intestine
Am J Physiol Gastrointest Liver Physiol, May 1, 2005; 288(5): G1074 - G1083.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
T. Brabletz, S. Spaderna, J. Kolb, F. Hlubek, G. Faller, C. J. Bruns, A. Jung, J. Nentwich, I. Duluc, C. Domon-Dell, et al.
Down-Regulation of the Homeodomain Factor Cdx2 in Colorectal Cancer by Collagen Type I: An Active Role for the Tumor Environment in Malignant Tumor Progression
Cancer Res., October 1, 2004; 64(19): 6973 - 6977.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
R.-J. Guo, E. Huang, T. Ezaki, N. Patel, K. Sinclair, J. Wu, P. Klein, E.-R. Suh, and J. P. Lynch
Cdx1 Inhibits Human Colon Cancer Cell Proliferation by Reducing {beta}-Catenin/T-cell Factor Transcriptional Activity
J. Biol. Chem., August 27, 2004; 279(35): 36865 - 36875.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
C. Jette, P. W. Peterson, I. T. Sandoval, E. J. Manos, E. Hadley, C. M. Ireland, and D. A. Jones
The Tumor Suppressor Adenomatous Polyposis Coli and Caudal Related Homeodomain Protein Regulate Expression of Retinol Dehydrogenase L
J. Biol. Chem., August 13, 2004; 279(33): 34397 - 34405.
[Abstract] [Full Text] [PDF]

Home page
 J. Cell Biol.Home page
P. Blache, M. van de Wetering, I. Duluc, C. Domon, P. Berta, J.-N. Freund, H. Clevers, and P. Jay
SOX9 is an intestine crypt transcription factor, is regulated by the Wnt pathway, and represses the CDX2 and MUC2 genes
J. Cell Biol., July 5, 2004; 166(1): 37 - 47.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
T. Hinoi, M. Loda, and E. R. Fearon
Silencing of CDX2 Expression in Colon Cancer via a Dominant Repression Pathway
J. Biol. Chem., November 7, 2003; 278(45): 44608 - 44616.
[Abstract] [Full Text] [PDF]

Home page
 GutHome page
C Bonhomme, I Duluc, E Martin, K Chawengsaksophak, M-P Chenard, M Kedinger, F Beck, J-N Freund, and C Domon-Dell
The Cdx2 homeobox gene has a tumour suppressor function in the distal colon in addition to a homeotic role during gut development
Gut, October 1, 2003; 52(10): 1465 - 1471.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
R. Kuefer, S. Varambally, M. Zhou, P. C. Lucas, M. Loeffler, H. Wolter, T. Mattfeldt, R. E. Hautmann, J. E. Gschwend, T. R. Barrette, et al.
{alpha}-Methylacyl-CoA Racemase: Expression Levels of this Novel Cancer Biomarker Depend on Tumor Differentiation
Am. J. Pathol., September 1, 2002; 161(3): 841 - 848.
[Abstract] [Full Text] [PDF]

Home page
 GutHome page
D Qualtrough, T Hinoi, E Fearon, and C Paraskeva
Expression of CDX2 in normal and neoplastic human colon tissue and during differentiation of an in vitro model system
Gut, August 1, 2002; 51(2): 184 - 190.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2001 by the American Society for Investigative Pathology.